Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

(Image Credit: AdobeStock/rohane) “Modern devices for delivering viscoelastics during viscocanaloplasty have changed greatly over the past few years, resulting in better outcomes with improved ergonomics and user-friendliness for the surgeons who are performing the procedures,” said Edward Yung, MD, of…

The CCOI Myopia Workshop in Paris on September 8, 2025, will bring together global experts to address the rising epidemic of myopia. (Image credit: AdobeStock/racesy) As myopia rates continue to climb globally—emerging as a major concern not only in Asia…

(Image credit: AdobeStock/Pixel-Shot) A study published in Ophthalmology Science shows that by analyzing up-to daily home OCT images, artificial intelligence (AI) can accurately track disease activity in patients with wet age-related macular degeneration (AMD). This may allow physicians to manage…
Molecules found in eye fluid offer new hope for glaucoma detection The Brighter Side of News Source: Author: | Date: 2025-08-27 14:07:00 Source: Author: | Date: 2025-08-27 14:07:00

In advance of the upcoming CCOI Myopia Workshop, scheduled for September 8 in Paris, France, Michael X. Repka, MD, MBA—program co-chair of the event and current president of the American Academy of Ophthalmology—spoke about the challenges and opportunities facing the…

(Image Credit: AdobeStock/Alessandro Grandini) Dry eye disease (DED), as defined by the Tear Film and Ocular Surface Society Dry Eye Workshop II (TFOS DEWS II), is a multifactorial disease of the ocular surface. It is characterized by a loss of…
Q&A: Daniela Ferrara on the potential of AI in retina Modern Retina Source: Author: | Date: 2025-08-26 22:49:00 Source: Author: | Date: 2025-08-26 22:49:00

Demonstration of the identifeye HEALTH device in use. Photo owned by identifeye HEALTH and used with permission identifeye HEALTH has launched its retinal screening platform and is now delivering results to patients through clinics and community programs. The platform is…

(Image Credit: AdobeStock) The first patient has been dosed in Qlaris Bio’s Phase II Nightingale clinical trial for QLS-111 in patients with normal tension glaucoma (NTG).1 The study, which is Qlaris Bio’s third phase 2 clinical trial of the company’s…

(Image Credit: AdobeStock/Mohammed) Cataract surgery in patients who have previously undergone refractive procedures, such as LASIK or radial keratotomy (RK), presents unique challenges, noted Steven J. Dell, MD, medical director of Dell Laser Consultants in Austin, Texas, during an Ophthalmology…